Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 4 45-4, 1999, Pages

  Fryer, Ryan M ^a   Schultz, Jo El J ^a   Hsu, Anna K ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Chelerythrine; Genistein; Ischemic preconditioning; Protein kinase C

Indexed keywords

CHELERYTHRINE; GENISTEIN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0032951513     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.4.h1229     Document Type: Article

References (36)

1. Akiyama, T., and H. Ogawara. Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol. 201: 362-371, 1991.
2. ATP channels, and ischemic preconditioning in dogs. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1327-H1336, 1993.
3. Baines, C., M. Cohen, and J. Downey. Protein tyrosine kinase inhibitor, genistein, blocks preconditioning in isolated rabbit hearts (Abstract). Circulation 94:I-661, 1996.
4. Baines, C., L. Wang, M. Cohen, and J. Downey. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J. Mol. Cell. Cardiol. 30: 383-392, 1998.
5. Fryer, R., J. Schultz, A. Hsu, and G. Gross. Pretreatment with tyrosine kinase inhibitors partially attenuates ischemic preconditioning in the rat heart. Am. J. Physiol. 275 (Heart Circ. Physiol. 44): H2009-H2015, 1998.
6. Gray, M., J. Karliner, and D. Mochly-Rosen. A selective ∈-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J. Biol. Chem. 272: 30945-30951, 1997.
7. Gross, G., and J. Auchampach. Blockade of the ATP-sensitive potassium channels prevents myocardial preconditioning. Circ. Res. 70: 223-233, 1992.
8. Joyeux, M., G. Baxter, D. Thomas, C. Ribuot, and D. Yellon. Protein kinase C is involved in resistance to myocardial infarction induced by heat stress. J. Mol. Cell. Cardiol. 29: 3311-3319, 1997.
9. Klein, H., S. Puschmann, J. Schaper, and W. Schaper. The mechanism of the tetrazolium reaction in identifying myocardial infarction. Virchows Arch. 393: 287-297, 1981.
10. + channels. Circ. Res. 79: 399-406, 1996.
11. 1 adenosine receptors in rabbit hearts. Circulation 84: 350-356, 1991.
12. Liu, Y., and J. Downey. Ischemic preconditioning protects against infarction in rat heart. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1107-H1112, 1992.
13. Maulik, N., M. Watanabe, Y. Zu, C. Huang, G. Cordis, J. Schley, and D. Das. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett. 396: 233-237, 1996.
14. ATP channel opener: effects on interstitial adenosine in dogs. J. Mol. Cell. Cardiol. 30: 1225-1236, 1998.
15. Miura, T., T. Miura, S. Kawamura, M. Goto, J. Sakamoto, A. Tsuchida, M. Matsuzaki, and K. Shimamoto. Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes. Cardiovasc. Res. 37: 700-709, 1998.
16. Murry, C., R. Jennings, and K. Reimer. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
17. Okajima, F., M. Akbar, M. Majid, K. Sho, H. Tomura, and Y. Kondo. Genistein, an inhibitor of protein tyrosine kinase, is also a competitive antagonist for P1-purinergic (adenosine) receptor in FRTL-5 thyroid cells. Biochem. Biophys. Res. Commun. 203: 1488-1495, 1994.
18. Paillart, C., E. Carlier, D. Guedin, B. Dargent, and F. Couraud. Direct block of voltage-sensitive sodium channels by genistein, a tyrosine kinase inhibitor. J. Pharmacol. Exp. Ther. 280: 521-526, 1997.
19. Ping, P., J. Zhang, Y. Qiu, X. Tang, S. Manchikalapudi, X. Cao, and R. Bolli. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ∈ and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ. Res. 81: 404-414, 1997.
20. Qian, Y., J. Shipley, J. Levassuer, and R. Kukreja. Dissociation of heat shock proteins' expression with ischemic tolerance by whole body hyperthermia in rat heart. J. Mol. Cell. Cardiol. 30: 1163-1172, 1998.
21. Rice, P., S. Armstrong, and C. Ganote. Concentration-response relationships for adenosine agonists during preconditioning of rabbit cardiomyocytes. J. Mol. Cell. Cardiol. 28: 1355-1365, 1996.
22. Sandhu, R., R. Diaz, G. Mao, and G. Wilson. Ischemic preconditioning: differences in protection and susceptibility to blockade with single-cycle versus multicycle transient ischemia. Circulation 984-995, 1997.
23. Schott, R., S. Rohmann, E. Braun, and W. Schaper. Ischemic preconditioning reduces infarct size in swine myocardium. Circ. Res. 66: 1133-1142, 1990.
24. Schultz, J., A. Hsu, J. Barbieri, P. Li, and G. Gross. Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am. J. Physiol. 275 (Heart Circ. Physiol. 44): H495-H500, 1998.
25. ATP channels. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H909-H914, 1998.
26. ATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J. Mol. Cell. Cardiol. 29: 1055-1060, 1997.
27. Schultz, J., E. Rose, Z. Yao, and G. Gross. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2157-H2161, 1995.
28. Schultz, J., Z. Yao, I. Cavero, and G. Gross. Glibenclamide-induced blockage of ischemic preconditioning is time dependent in intact rat heart. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H2607-H2615, 1997.
29. Speechly-Dick, M., M. Mocanu, and D. Yellon. Protein kinase C: its role in ischemic preconditioning in the rat. Circ. Res. 75: 586-590, 1994.
30. + channel blocker. Circulation 90: 700-705, 1994.
31. Tosaki, A., N. Maulik, D. Engelman, R. Engelman, and D. Das. The role of protein kinase C in ischemic/reperfused preconditioned isolated rat hearts. J. Cardiovasc. Pharmacol. 28: 723-731, 1996.
32. Tzivoni, D., and S. Maybaum. Attenuation of severity of myocardial ischemia during repeated daily ischemic episodes. J. Am. Coll. Cardiol. 30: 119-124, 1997.
33. Vahlhaus, C., R. Schulz, H. Post, J. Rose, and G. Heusch. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J. Mol. Cell. Cardiol. 30: 197-209, 1998.
34. Weinbrenner, C., G. Liu, M. Cohen, and J. Downey. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J. Mol. Cell. Cardiol. 29: 2383-2391, 1997.
35. Yang, X., H. Sato, J. Downey, and M. Cohen. Protection of ischemic preconditioning is dependant upon a critical timing sequence of protein kinase C activation. J. Mol. Cell. Cardiol. 29: 991-999, 1997.
36. Ytrehus, K., Y. Liu, and J. Downey. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1145-H1152, 1994.